Clinical Trials Logo

Clinical Trial Summary

AstraGin increases the absorption of amino acids and peptides in Caco-2 cells and in normal and TNBS-induced rats. Given the potential beneficial applications of AstraGin for health, the effects on L-arginine uptake and nitric oxide production are investigated. The study is the L-arginine pharmacokinetic study: A randomized, double-blind, crossover trial. This study performed in healthy human subjects. The knowledge gained from this study will provide valuable information for the development of novel and effective natural food supplements.


Clinical Trial Description

n/a


Study Design


NCT number NCT05024123
Study type Interventional
Source Chung Shan Medical University
Contact
Status Enrolling by invitation
Phase N/A
Start date April 6, 2021
Completion date May 2022